Aster DM Quality Care News and Updates

Name: Latest research reports of Aster DM Quality Care Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Aster DM Quality Care Ltd.
Rating: 5
Author: Motilal Oswal

Keep track of all breaking news on Aster DM Quality Care from all sources in a single place.

Aster DM Quality Care Ltd.

28 Sep 2026

699.85

3.35%

MOFSL initiates 'Buy' coverage on Aster DM; bets on pan-India hospital play

Business Standard

MOFSL's bullish nod came as Aster DM recently merged with Quality Care India, with the brokerage firm noting that, the Aster DM Healthcare-QCIL merger creates one of India's largest hospital platforms

Institutional Investors have decreased holdings from 44.75% to 38.18% in Jun 2026 qtr

Aster DM Quality Care Ltd.

28 Sep 2026

699.85

3.35%

Building a healthcare giant

Buy: Aster DM Quality Care Ltd.

Motilal Oswal

The Aster DM Healthcare–QCIL merger creates one of India's largest hospital platforms, Aster DM Quality Care (AsterDM), with 39 hospitals and ~10,600 operational beds across 28 cities.

Institutional Investors have decreased holdings from 44.75% to 38.18% in Jun 2026 qtr

Aster DM Quality Care Ltd.

04 Sep 2026

699.85

3.35%

Moopen family raises stake in Aster DM Quality Care to 24.58% as TPG pares holding

Business Line

Union (Mauritius) Holdings Ltd, owned and promoted by Dr Moopen and his family, acquired 46.09 lakh equity shares of Aster DM Quality Care at 760 apiece on September 2

Number of FII/FPI investors increased from 214 to 229 in Jun 2026 qtr.

Moopen family raises stake in Aster DM Quality Care to 24.58% as TPG pares holding

Business Line | 04 Sep 2026 2 more

Aster DM Quality Care Ltd.

01 Sep 2026

699.85

3.35%

Aster DM's KIMS Health to add 184 beds at Thiruvananthapuram hospital

Business Line

The project will address space constraints and support expansion of key specialties, with completion targeted by May 2028

FII/FPI have decreased holdings from 17.18% to 10.53% in Jun 2026 qtr

Aster DM Quality Care Ltd.

29 Aug 2026

699.85

3.35%

Aster DM Quality Care subsidiary buys 14.21% stake in STS Holdings for $44.11 million

Business Line

The acquisition follows a merger framework agreement signed in November 2024 and received approval from the NCLT Hyderabad bench in June 2026

Aster DM Quality Care Ltd. is trading below all available SMAs

Aster DM Quality Care Ltd.

21 Aug 2026

699.85

3.35%

Aster DM Quality Care

Buy: Aster DM Quality Care Ltd.

Target

ICICI Direct

Standalone Aster revenues grew ~22% YoY to 1311 crore aided by ~10% growth in Average Revenue Per Patient (IP) to 130352 and 16% growth in the total patient volumes. Occupancies improved by 350 bps YoY to 62% led by higher IP volume growth. EBITDA grew ~27% YoY to 264 crore, driven by operating leverage and disciplined cost management. Margins stood at ~20% (up 93 bps YoY). Combined entity Q1FY27 numbers are presented on a pro forma basis, as the merger became effective only on July 1, 2026. Combined revenues grew 20% YoY to 2,597 crore, EBITDA increased 30% YoY to 576...

Institutional Investors have decreased holdings from 44.75% to 38.18% in Jun 2026 qtr

Aster DM Quality Care Ltd.

20 Aug 2026

699.85

3.35%

TPG sells 6.66% stake in Aster DM Quality Care for 4,451 crore

Business Line

The large block transaction reshaped the hospital operator's shareholder base, with institutional investors emerging as significant buyers of the shares

FII/FPI have decreased holdings from 17.18% to 10.53% in Jun 2026 qtr

Aster DM block deal: 65.6mn shares change hands; stock up 8% from day's low

Business Standard | 19 Aug 2026

Aster DM Quality Care Ltd.

07 Aug 2026

699.85

3.35%

Broker's Call: Aster DM Healthcare (Buy)

Business Line

Prabhudas Lilladhar

Institutional Investors have decreased holdings from 44.75% to 38.18% in Jun 2026 qtr

Aster DM Quality Care Ltd.

06 Aug 2026

699.85

3.35%

Merger synergies to boost growth trajectory

Hold: Aster DM Quality Care Ltd.

Recommendation Target

ICICI Securities Limited

Aster’s merger with QCIL was completed in Jul’26. Both entities reported strong performance, with Aster’s revenue / EBITDA growing 21.6%/27.5% YoY led by traction and improved profitability in new units.